Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer

Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer

Abstract Background Currently, there is no reliable blood-based marker to track tumor recurrence in endometrial cancer (EC) patients. Liquid biopsies, specifically, circulating tumor DNA (ctDNA) analysis emerged as a way to monitor tumor metastasis. The objective of this study was to examine the fea...

Full description

Bibliographic Details
Main Authors: Weiwei Feng, Nan Jia, Haining Jiao, Jun Chen, Yan Chen, Yueru Zhang, Menghan Zhu, Chongying Zhu, Lifei Shen, Wenqing Long
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Journal of Translational Medicine
Subjects:
Circulating tumor DNA
High-risk
endometrial cancer
Recurrence
Online Access:https://doi.org/10.1186/s12967-021-02722-8

Internet

https://doi.org/10.1186/s12967-021-02722-8

Similar Items